Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: A prospective, randomized, double-blind trial

Annals of Emergency Medicine

Volumn 41, Issue 6, 2003, Pages 847-853

  Tanen, David A ^a   Miller, Sharon ^a,b   French, Tonianne ^a   Riffenburgh, Robert H ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b NAVAL HOSPITAL JACKSONVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; PROCHLORPERAZINE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MIGRAINE; NAUSEA; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; VISUAL ANALOG SCALE;

EID: 0038175380     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.195     Document Type: Article

References (17)

1. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26:541-546.
2. Tek DS, McClellan DS, Olshaker JS, et al. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 1990;19:1083-1087.
3. Treves TA, Streiffler M, Korczyn AD. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache. 1992;32:280-282.
4. Larkin GL, Prescott JE. A randomized double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med. 1992;21:919-924.
5. Carleton SC, Shesser RF, Pietrzak MP, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department of acute migraine headache. Ann Emerg Med. 1998;32:129-138.
6. Seim MB, March JA, Dunn KA. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1998;5:573-576.
7. Winner P, Ricalde O, Le Force B, et al. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53:180-184.
8. Jones J, Sklar D, Dougherty J, et al. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989;261:1174-1176.
9. Rothrock JF. Clinical studies of valproate for migraine prophylaxis. Cephalgia. 1997;17:81-83.
10. Mathew NT, Kailasam J, Meadors L, et al. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40:720-723.
11. Norton J. Use of intravenous valproate sodium in status migraine. Headache. 2002;40:755-757.
12. Kozubski W, Prusinski A. The comparison of sodium valproate and ergotamine citrate plus caffeine in the abortive treatment of migraine attacks. Neur Neurochir Pol. 1995;29:929-935.
13. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41:976-980.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalgia. 1988;8(suppl 7):1-96.
15. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs. 1998;56:811-824.
16. Ayd FJ. A survey of drug induced extrapyramidal reactions. JAMA. 1961;175:1054-1060.
17. Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders. A study of 125 patients. South Med J. 1990;83:525-532.